by Clinical Neuropsychologist | Thursday, April 10, 2025 | Neuroimaging
ABSTRACT Background and Purpose Peripheral nerve stimulation is approved by the US Food and Drug Administration for treating various disorders, but it is often limited by side effects, highlighting the need for a clear understanding of fascicular and fiber...
by Clinical Neuropsychologist | Tuesday, April 8, 2025 | Neuroimaging
ABSTRACT Background and Purpose Temporal lobe epilepsy is the most common form of focal epilepsy. MR-guided laser interstitial thermal therapy (LITT) of the amygdalohippocampal complex has become an established therapy option in case of drug resistance. Long-term...
by Clinical Neuropsychologist | Friday, March 28, 2025 | Neuroimaging
ABSTRACT Background and Purpose Parenchymal hematomas (PHs) represent an important complication in ischemic stroke after endovascular thrombectomy (EVT), but the risk factors are incompletely understood. Neuroimaging data preintervention, such as infarct topography,...
by Clinical Neuropsychologist | Wednesday, March 26, 2025 | Neuroimaging
ABSTRACT Background and Purpose 99mTc-TRODAT-1 SPECT imaging is an imaging technique, more commonly used in Asia, to diagnose Parkinson’s disease (PD). This study evaluates the use of automated three-dimensional volume-of-interest (VOI) analysis in diagnosing...
by Clinical Neuropsychologist | Wednesday, March 19, 2025 | Neuroimaging
ABSTRACT Background and Purpose Extensive research has been carried out to investigate changes in various gray matter (GM) regions during the aging process using resting-state functional MRI. However, the impact of aging on the functional connectivity (FC) between...
by Clinical Neuropsychologist | Wednesday, March 19, 2025 | Neuroimaging
ABSTRACT Background and Purpose Cladribine, an FDA-approved disease-modifying immunotherapy for multiple sclerosis (MS), penetrates the CSF and mitigates T cells and B cells, and thus may impact the development of cortical gray matter lesions (CLs) and leptomeningeal...
